Discovery of tetrahydrocarbazoles with potent hypoglycemic and hypolipemic activities

European Journal of Medicinal Chemistry
2018.0

Abstract

A series of tetrahydrocarbazole derivatives was designed and synthesized on the basis of the AMP-activated protein kinase activator GY3. All the synthesized compounds were screened in HepG2 cell lines for glucose consumption activity and several of them showed potent glucose decreasing activity. In vivo evaluation of the hypoglycemic and hypolipemic effects indicated that 7a exhibited comparable activity with pioglitazone, but with a weaker body-weight increasing effect. The pharmacokinetic profiles of 7a were also investigated.

Knowledge Graph

Similar Paper

Discovery of tetrahydrocarbazoles with potent hypoglycemic and hypolipemic activities
European Journal of Medicinal Chemistry 2018.0
Synthesis and in vivo antihyperglycemic activity of 5-(1H-pyrazol-3-yl)methyl-1H-tetrazoles
Bioorganic & Medicinal Chemistry Letters 2005.0
Design, synthesis and biological evaluation of GY3-based derivatives for anti-type 2 diabetes activity
Bioorganic & Medicinal Chemistry Letters 2015.0
Novel berberine-based derivatives with potent hypoglycemic activity
Bioorganic & Medicinal Chemistry Letters 2019.0
Studies on antidiabetic agents. 11. Novel thiazolidinedione derivatives as potent hypoglycemic and hypolipidemic agents
Journal of Medicinal Chemistry 1992.0
Synthesis, glucose uptake activity and structure–activity relationships of some novel glitazones incorporated with glycine, aromatic and alicyclic amine moieties via two carbon acyl linker
European Journal of Medicinal Chemistry 2011.0
Novel glitazones: glucose uptake and cytotoxic activities, and structure–activity relationships
Medicinal Chemistry Research 2012.0
Synthesis and Mechanism of Hypoglycemic Activity of Benzothiazole Derivatives
Journal of Medicinal Chemistry 2013.0
Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4-quinoxalinyl)ethoxy]phenyl]methylene]thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents
Bioorganic & Medicinal Chemistry Letters 2005.0
Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus
Bioorganic & Medicinal Chemistry Letters 2013.0